Phone: (212) 746-5788
Fax: (212) 746-0975
November 19, 2009 9:27 am
Neoadjuvant VEGF-Targeted Therapy in Renal Cell Carcinoma
Recent therapeutic advances in metastatic renal cell carcinoma (RCC) have included agents targeted against vascular endothelial growth factor (VEGF).
|